Myelodysplastic syndrome after allogeneic hematopoietic stem cell transplantation: diagnostic and therapeutic challenges

about

A Study of Human Leukocyte Antigen Mismatched Cellular Therapy (Stem Cell Microtransplantation) in High-Risk Myelodysplastic Syndrome or Transformed Acute Myelogenous Leukemia.

P2860

Q36703031-AAD5B648-25D0-409A-A3A2-07E01566480C

P2860

Myelodysplastic syndrome after allogeneic hematopoietic stem cell transplantation: diagnostic and therapeutic challenges

Item

http://www.wikidata.org/entity/Q36266642

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

Myelodysplastic syndrome after ...... tic and therapeutic challenges

@ast

Myelodysplastic syndrome after ...... tic and therapeutic challenges

@en

type

Item

label

Myelodysplastic syndrome after ...... tic and therapeutic challenges

@ast

Myelodysplastic syndrome after ...... tic and therapeutic challenges

@en

prefLabel

Myelodysplastic syndrome after ...... tic and therapeutic challenges

@ast

Myelodysplastic syndrome after ...... tic and therapeutic challenges

@en

P1476

Myelodysplastic syndrome after ...... tic and therapeutic challenges

@en

P2093

Alan S Wayne

http://www.w3.org/2001/XMLSchema#string

Barbara Wise

http://www.w3.org/2001/XMLSchema#string

Diane C Arthur

http://www.w3.org/2001/XMLSchema#string

Katherine R Calvo

http://www.w3.org/2001/XMLSchema#string

Kristin Baird

http://www.w3.org/2001/XMLSchema#string

Maryalice Stetler-Stevenson

http://www.w3.org/2001/XMLSchema#string

Michael Bishop

http://www.w3.org/2001/XMLSchema#string

Nancy M Hardy

http://www.w3.org/2001/XMLSchema#string

Nirali N Shah

http://www.w3.org/2001/XMLSchema#string

Roger Kurlander

http://www.w3.org/2001/XMLSchema#string

P2860

Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study

Prospective validation of the WHO proposals for the classification of myelodysplastic syndromes

Lenalidomide in the myelodysplastic syndrome with chromosome 5q deletion.

Maintenance therapy with low-dose azacitidine after allogeneic hematopoietic stem cell transplantation for recurrent acute myelogenous leukemia or myelodysplastic syndrome: a dose and schedule finding study.

NCCN Clinical Practice Guidelines in Oncology: myelodysplastic syndromes.

Donor cell-derived leukemias/myelodysplastic neoplasms in allogeneic hematopoietic stem cell transplant recipients: a clinicopathologic study of 10 cases and a comprehensive review of the literature.

Allogeneic transplantation for therapy-related myelodysplastic syndrome and acute myeloid leukemia.

Donor cell leukemia: a review.

Hematopoietic stem cell transplantation for MDS.

Donor cell leukemia: report of a case occurring 11 years after allogeneic bone marrow transplantation and review of the literature.

P304

916-922

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/AJH.23174

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Ulrike Bacher

Sergio Giralt

P577

2012-04-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

223986335

http://www.w3.org/2001/XMLSchema#string

P698

22473867

http://www.w3.org/2001/XMLSchema#string

P932

3454494

http://www.w3.org/2001/XMLSchema#string

Myelodysplastic syndrome after allogeneic hematopoietic stem cell transplantation: diagnostic and therapeutic challenges

about

P2860

P2860

Myelodysplastic syndrome after allogeneic hematopoietic stem cell transplantation: diagnostic and therapeutic challenges

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P932